Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Niagen Bioscience (NAGE) Times Interest Earned (2016 - 2022)

Historic Times Interest Earned for Niagen Bioscience (NAGE) over the last 14 years, with Q3 2022 value amounting to -$613.0.

  • Niagen Bioscience's Times Interest Earned fell 400.41% to -$613.0 in Q3 2022 from the same period last year, while for Jun 2023 it was -$1758.6, marking a year-over-year decrease of 16121.52%. This contributed to the annual value of -$492.24 for FY2021, which is 7602.89% down from last year.
  • Latest data reveals that Niagen Bioscience reported Times Interest Earned of -$613.0 as of Q3 2022, which was down 400.41% from -$638.7 recorded in Q2 2022.
  • In the past 5 years, Niagen Bioscience's Times Interest Earned ranged from a high of $1265.7 in Q4 2019 and a low of -$966.5 during Q1 2022
  • For the 5-year period, Niagen Bioscience's Times Interest Earned averaged around -$274.43, with its median value being -$380.06 (2020).
  • Data for Niagen Bioscience's Times Interest Earned shows a peak YoY increase of 28774.67% (in 2018) and a maximum YoY decrease of 125327.46% (in 2018) over the last 5 years.
  • Niagen Bioscience's Times Interest Earned (Quarter) stood at $374.55 in 2018, then surged by 237.93% to $1265.7 in 2019, then plummeted by 130.03% to -$380.06 in 2020, then tumbled by 55.41% to -$590.67 in 2021, then decreased by 3.78% to -$613.0 in 2022.
  • Its Times Interest Earned was -$613.0 in Q3 2022, compared to -$638.7 in Q2 2022 and -$966.5 in Q1 2022.